MX2015007065A - Metodo y composiciones para tratar diarrea asociada con vih. - Google Patents
Metodo y composiciones para tratar diarrea asociada con vih.Info
- Publication number
- MX2015007065A MX2015007065A MX2015007065A MX2015007065A MX2015007065A MX 2015007065 A MX2015007065 A MX 2015007065A MX 2015007065 A MX2015007065 A MX 2015007065A MX 2015007065 A MX2015007065 A MX 2015007065A MX 2015007065 A MX2015007065 A MX 2015007065A
- Authority
- MX
- Mexico
- Prior art keywords
- subject
- methods
- hiv
- composition
- associated diarrhea
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 206010012735 Diarrhoea Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 229920001393 Crofelemer Polymers 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 2
- 208000037357 HIV infectious disease Diseases 0.000 abstract 2
- 238000011225 antiretroviral therapy Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940047615 crofelemer Drugs 0.000 abstract 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 2
- ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 abstract 2
- 230000008406 drug-drug interaction Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En la presente se proporcionan los métodos para tratar diarrea asociada con VIH o asociada con terapia anti-retroviral altamente activa (TARAA) en un individuo VIH positivo, administrando al individuo una composición que contiene crofelemer, en donde la composición tiene mínimas interacciones fármaco-fármaco, con al menos otro compuesto administrado en forma concurrente al individuo para tratar una infección por VIH. También se proporcionan los métodos para tratar diarrea asociada con VIH o diarrea asociada con terapia anti-retroviral altamente activa (TARAA) en un individuo VIH positivo, administrando al individuo una composición que contiene crofelemer, en donde la composición no inhibe significativamente la actividad de al menos otro compuesto administrado en forma concurrente al individuo para tratar una infección por VIH.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261734901P | 2012-12-07 | 2012-12-07 | |
| PCT/US2013/032395 WO2014088629A1 (en) | 2012-12-07 | 2013-03-15 | Methods and compositions for treating hiv-associated diarrhea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015007065A true MX2015007065A (es) | 2017-03-01 |
Family
ID=50881628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015007065A MX2015007065A (es) | 2012-12-07 | 2013-03-15 | Metodo y composiciones para tratar diarrea asociada con vih. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20140163096A1 (es) |
| EP (1) | EP2928560A4 (es) |
| JP (1) | JP2016505561A (es) |
| CA (1) | CA2893070A1 (es) |
| MX (1) | MX2015007065A (es) |
| WO (1) | WO2014088629A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG161259A1 (en) | 2006-05-01 | 2010-05-27 | Napo Pharmaceuticals Inc | Method for treatment of constipation-predominant irritable bowel syndrome |
| US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| EP2529626B1 (en) | 2006-05-01 | 2017-11-22 | Napo Pharmaceuticals, Inc. | Compositions and methods for treating or preventing colon cancer |
| PE20140036A1 (es) | 2010-10-31 | 2014-01-31 | Napo Pharmaceuticals Inc | Metodos y composiciones para tratar diarrea asociada con vih |
| EP3129009A1 (en) * | 2014-04-08 | 2017-02-15 | Teva Pharmaceutical Industries Ltd | Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir |
| US10380937B2 (en) | 2015-08-26 | 2019-08-13 | Apple Inc. | Multi-zoned variable VCOM control |
| WO2020180424A1 (en) | 2019-03-04 | 2020-09-10 | Iocurrents, Inc. | Data compression and communication using machine learning |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1525216A4 (en) * | 2002-01-24 | 2009-07-08 | Sangstat Medical Corp | COMBINATION THERAPY FOR THE TREATMENT OF HIV INFECTION |
| EP1962829A1 (en) * | 2005-12-15 | 2008-09-03 | Bayer HealthCare AG | Diaryl ureas for treating virus infections |
| US7928115B2 (en) * | 2008-10-02 | 2011-04-19 | Salix Pharmaceuticals, Ltd. | Methods of treating travelers diarrhea and hepatic encephalopathy |
| PE20140036A1 (es) * | 2010-10-31 | 2014-01-31 | Napo Pharmaceuticals Inc | Metodos y composiciones para tratar diarrea asociada con vih |
-
2013
- 2013-03-15 MX MX2015007065A patent/MX2015007065A/es unknown
- 2013-03-15 CA CA2893070A patent/CA2893070A1/en not_active Abandoned
- 2013-03-15 WO PCT/US2013/032395 patent/WO2014088629A1/en not_active Ceased
- 2013-03-15 EP EP13860056.4A patent/EP2928560A4/en not_active Withdrawn
- 2013-03-15 US US13/840,861 patent/US20140163096A1/en not_active Abandoned
- 2013-03-15 JP JP2015546448A patent/JP2016505561A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014088629A1 (en) | 2014-06-12 |
| EP2928560A1 (en) | 2015-10-14 |
| US20140163096A1 (en) | 2014-06-12 |
| CA2893070A1 (en) | 2014-06-12 |
| EP2928560A4 (en) | 2016-06-01 |
| JP2016505561A (ja) | 2016-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015007065A (es) | Metodo y composiciones para tratar diarrea asociada con vih. | |
| MX2016004492A (es) | Inhibidores de la replicacion del virus de inmunodeficiencia humana (vih). | |
| AR093386A1 (es) | Composicion para tratar la diabetes o la diabesidad que comprende un analogo de oxintomodulina y metodo de tratamiento | |
| NZ702663A (en) | Nuclear transport modulators and uses thereof | |
| MX365939B (es) | Moduladores del transporte nuclear y usos de los mismos. | |
| PH12014501702A1 (en) | Imidazopyrrolidinone compounds | |
| PH12015501576A1 (en) | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | |
| BR112015011933A2 (pt) | composições bacterianas sinérgicas e métodos de produção e uso das mesmas | |
| BR112013027119A8 (pt) | novos conjugados ligante-droga (adcs) e uso dos mesmos | |
| MX2017004580A (es) | Combinaciones de auristatina sinergica. | |
| PH12015501887B1 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
| MX2014002555A (es) | Una composicion farmacéutica para tratar cáncer, que comprende un conjugado de interferón alfa. | |
| PH12015501888A1 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
| AR108021A1 (es) | Conjugados de anticuerpo-principio activo (adcs) de inhibidores de ksp con anticuerpos anti-b7h3 | |
| NZ601559A (en) | Platelet-derived growth factor compositions and methods for the treatment of tendinopathies | |
| NZ702087A (en) | Pharmaceutical compositions and treatment of mastitis | |
| TW201613592A (en) | Glucose metabolism ameliorating agent | |
| PH12013500857A1 (en) | Methods and compositions for treating hiv-associated diarrhea | |
| MX2014000567A (es) | Tratamiento de lesion por radiacion utilizando celulas adherentes derivadas del amnios. | |
| MX343589B (es) | Leucotoxina e/d como agente anti-inflamatorio novedoso y microbicida. | |
| MX2020011107A (es) | Regimen de glicosidasa para el tratamiento de enfermedades infecciosas. | |
| MX371329B (es) | Factor de creciemiento similar a la insulina (igf) activo y su uso en infecciones por el virus del síndrome reproductivo y respiratorio porcino (prrsv). | |
| PH12020552241A1 (en) | Use of polar lipids to treat or prevent gestational diabetes mellitus | |
| GB2525517A (en) | Topical preparation for pain relief | |
| EA201590796A1 (ru) | Фибринолитические композиции, включающие бромелаин и наттокиназу, для предотвращения и лечения флеботромботических состояний |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assignment |
Owner name: NAPO PHARMACEUTICALS, INC. |